Jonathan Monson - 14 Jun 2021 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
VP, Global Controller and CAO
Signature
/s/ Vance R. Brown, Attorney-in-fact
Issuer symbol
BSX
Transactions as of
14 Jun 2021
Net transactions value
-$385,494
Form type
4
Filing time
16 Jun 2021, 16:22:30 UTC
Next filing
17 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $65,400 +5,000 +13% $13.08 42,062 14 Jun 2021 Direct F1
transaction BSX Common Stock Sale $214,700 -5,000 -12% $42.94 37,062 14 Jun 2021 Direct F1
transaction BSX Common Stock Options Exercise $101,844 +7,901 +21% $12.89 44,963 15 Jun 2021 Direct F1
transaction BSX Common Stock Sale $338,038 -7,901 -18% $42.78 37,062 15 Jun 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Stock Option (Right to Buy) Options Exercise $0 -5,000 -100% $0.000000* 0 14 Jun 2021 Common Stock 5,000 $13.08 Direct F1, F3
transaction BSX Stock Option (Right to Buy) Options Exercise $0 -7,901 -44% $0.000000 10,000 15 Jun 2021 Common Stock 7,901 $12.89 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2 Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.63 to $42.93, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Grant to the reporting person on February 24, 2014, of an option to purchase 15,000 shares of common stock.
F4 Grant to the reporting person on December 1, 2014, of an option to purchase 17,901 shares of common stock.